80 results
Page 3 of 4
8-K
EX-99.1
3ffou x62e13i75wcl
17 Feb 22
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
4:02pm
8-K
EX-99.1
wumxme dxlhdz
10 Jan 22
Regulation FD Disclosure
10:38am
424B3
eqhs8ikt
22 Dec 21
Prospectus supplement
5:07pm
8-K
EX-99.1
tkvdedfwafu0xpsh
7 Dec 21
Regulation FD Disclosure
4:51pm
8-K
EX-99.1
l41sn qsrmc
3 Dec 21
Longeveron Inc. Announces Pricing of a $20.5 Million Private Placement
5:13pm
8-K
EX-99.2
qj4j2me 0v1hz0
3 Dec 21
Longeveron Inc. Announces Pricing of a $20.5 Million Private Placement
5:13pm
8-K
EX-99.1
mcm5fxvdjf25
18 Nov 21
U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat
4:58pm
8-K
EX-99.1
qjfy80sb
12 Nov 21
Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial Results
8:00am
8-K
EX-99.2
03yw2h2 lurft8r
1 Oct 21
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
8ssasac6
9 Sep 21
Regulation FD Disclosure
9:28am
8-K
EX-99.1
91jkwf2 qsg
13 Aug 21
Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty
1:46pm
8-K
EX-99.1
fiywfv n84
13 Aug 21
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results
10:32am
8-K
EX-99.1
hoevna pzh2
25 May 21
Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors
10:15am
10-Q
ct4m6t
14 May 21
Quarterly report
4:08pm
8-K
EX-99.1
84ot2 g3rjah
14 May 21
Results of Operations and Financial Condition
8:54am
8-K
EX-99.1
3dhjgr3b
11 May 21
Regulation FD Disclosure
11:42am
8-K
EX-99.1
3022nrk
15 Apr 21
Regulation FD Disclosure
9:08am